Eric C. Hsu - Dec 23, 2023 Form 4 Insider Report for InMed Pharmaceuticals Inc. (INM)

Role
Sr. VP, Pre-Clinical Res/Dev
Signature
/s/ Eric A. Adams, attorney-in-fact for Mr. Eric C. Hsu
Stock symbol
INM
Transactions as of
Dec 23, 2023
Transactions value $
$0
Form type
4
Date filed
12/26/2023, 01:07 PM
Previous filing
Aug 31, 2023
Next filing
Mar 5, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INM Employee Stock Option (Right to Buy) Award $0 +45K +572.96% $0.00 52.9K Dec 23, 2023 Common shares 45K $0.37 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options were granted on 12/23/2023 and will vest in equal installments monthly over 36 months (1/36 per month).